Skip to content
10-K

Annual Report

RESHAPE LIFESCIENCES INC.

0001558370-20-004843

← back to feed
Filed
Apr 30, 2020 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2019 · Apr 28, 2020 5.48M sh
Capex FY 2019 · Dec 31, 2019 $14K
Capex restated FY 2019 · Dec 31, 2018 $49K
Operating Cash Flow restated FY 2019 · Dec 31, 2018 −$27.49M
Cash And Equivalents restated FY 2019 · Dec 31, 2018 $5.55M
Current Liabilities restated FY 2019 · Dec 31, 2018 $8.36M
Total Liabilities restated FY 2019 · Dec 31, 2018 $14.61M
Current Assets restated FY 2019 · Dec 31, 2018 $8.72M
Total Assets restated FY 2019 · Dec 31, 2018 $46.27M
Sga Expense restated FY 2019 · Dec 31, 2018 $5.24M
Rd Expense restated FY 2019 · Dec 31, 2018 $5.72M
Net Income restated FY 2019 · Dec 31, 2018 −$81.15M
Operating Income restated FY 2019 · Dec 31, 2018 −$38.55M
Gross Profit restated FY 2019 · Dec 31, 2018 $443K
Revenue restated FY 2019 · Dec 31, 2018 $607K
Stockholders Equity restated FY 2019 · Dec 31, 2017 $76.37M